https://www.selleckchem.com/products/ldc7559.html
Of 36 people with evaluable outcomes, 35 (97%) survived and 22 (58%) had treatment success, including 12 of 19 (63%) with Mycobacterium abscessus group. In multivariate analysis, patients with Mycobacterium abscessus group were more likely to experience treatment success (OR 18.22, 95%CI 0.972-341.43, p=0.052), while macrolide resistance predicted a lack of treatment success (OR 0.053, 95%CI 0.003-0.841, p=0.037). Clofazimine was well-tolerated. Adding clofazimine to multi-class antibiotic regimens for drug-resistant NTM infection led t
Like
Comment
Share
